Head-to-Head

Boston Scientific Corp. vs. LeMaitre Vascular, Inc.

BSX

Boston Scientific Corp.

$49.31 +0.02%

VS LMAT

LeMaitre Vascular, Inc.

$81.45 +0.78%

Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 9 compared factors.

Size & Scale

BSXLMAT
Market Cap $71.46 billion $1.86 billion
Revenue (TTM) $21.00 billion $262.43 million
Net Income (TTM) $3.67 billion $65.67 million

BSX leads on 3 of 3 size & scale factors.

Valuation

BSXLMAT
P/E Ratio 19.96 28.58
Price / Book 2.84 4.43
Price / Sales 3.40 7.10

BSX leads on 3 of 3 valuation factors.

Profitability

BSXLMAT
Net Margin 17.47% 25.02%
Return on Equity 14.58% 15.62%

LMAT leads on 2 of 2 profitability factors.

Dividend

BSXLMAT
Dividend Yield — 1.23%
Payout Ratio — 35.09

BSX and LMAT split the dividend factors evenly.

Risk & Sentiment

BSXLMAT
Short Interest 0.72% 4.36%

BSX leads on 1 of 1 risk & sentiment factors.

Dig deeper: BSX overview, BSX financials, LMAT overview, LMAT financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.